TRIB
Trinity Biotech
$6.63
−$0.17 (−2.5%)Oct 29, 2026
Key metrics
The numbers that frame TRIB today
- Market cap
- $4.13M
- Gross margin
- 38.6%
- EV / Sales
- 3.1
- ROIC
- -20.3%
- Div yield
- 0%
- 52wk Low
- $5.01
- 52wk High
- $52.50
Growth
Revenue and earnings trend for TRIB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TRIB
Is Trinity Biotech a good buy?
No. Trinity Biotech has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Trinity Biotech is selling at a very high price.
What is the market capitalization of TRIB?
Trinity Biotech's market capitalization is $4.13M.
What is the 52-week high for TRIB stock?
The 52-week high for Trinity Biotech is $52.50. The current close of $6.63 is 87.4% below that high.
What is the 52-week low for TRIB stock?
The 52-week low for Trinity Biotech is $5.01. The current close of $6.63 is 32.3% above that low.
Does TRIB stock pay dividends?
Trinity Biotech does not currently show a dividend per share in the company data.